HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: AJPH.2008.142166v1 99/8/1491    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Deiss, R. Articles by Strathdee, S. A. Search for Related Content PubMed PubMed Citation Articles by Deiss, R. Articles by Strathdee, S. A. Related Collections Epidemiology Health Policy Tuberculosis Hispanics/Latinos Drugs

Robert Deiss, MD, Richard S. Garfein, PhD, Remedios Lozada, MD, Jose Luis Burgos, MD, Kimberly C. Brouwer, PhD, Kathleen S. Moser, MD, Maria Luisa Zuniga, PhD, Timothy C. Rodwell, MD, Victoria D. Ojeda, PhD and Steffanie A. Strathdee, PhD

Robert Deiss, Richard S. Garfein, Jose Luis Burgos, Kimberly C. Brouwer, Maria Luisa Zuniga, Timothy C. Rodwell, Victoria D. Ojeda, and Steffanie A. Strathdee are with the Department of Family and Preventive Medicine, Division of International Health and Cross-Cultural Medicine, School of Medicine, University of California, San Diego. Remedios Lozada is with Patronato Pro-Comusida, Tijuana, Mexico. Kathleen S. Moser is with the County of San Diego Health and Human Services Agency, San Diego.

Correspondence: Correspondence should be sent to Steffanie A. Strathdee, PhD, 9500 Gilman Dr, Mailstop 0622, La Jolla, CA 92093 (e-mail: sstrathdee{at}ucsd.edu). Reprints can be ordered at http://www.ajph.org by clicking on the "Reprints/Eprints" link.

Objectives. We sought to identify correlates of reported lifetime diagnoses of TB among injection drug users in the border city of Tijuana, Mexico.

Methods. Injection drug users in Tijuana were recruited into a prospective cohort study during 2006 and 2007. We used weighted multivariate logistic regression to identify correlates of TB diagnoses.

Results. Of the 1056 participants, 103 (9.8%) reported a history of TB, among whom 93% received anti-TB medication and 80% were diagnosed in the United States. Treatment was prematurely halted among 8% of patients; deportation from the United States was the cause of half of these treatment interruptions. History of travel to (odds ratio [OR] = 6.44; 95% confidence interval [CI] = 1.53, 27.20) or deportation from (OR = 1.83; 95% CI = 1.07, 3.12) the United States and incarceration (OR = 2.20; 95% CI = 1.06, 4.58) were independently associated with a reported lifetime diagnosis of TB.

Conclusions. Mobility and migration are important factors in identifying and treating TB patients diagnosed in the US–Mexico border region. Strengthening capacity on both sides of the border to identify, monitor, and treat TB is a priority.